The spirometer market size has grown strongly in recent years. It will grow from $1.2 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased prevalence of respiratory diseases, growing emphasis on preventive healthcare, aging population demographic, clinical research and evidence-based practices.
The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to shift towards home healthcare, continue clinical research, medical reimbursement policies, occupational health monitoring. Major trends in the forecast period include remote monitoring and telemedicine, patient engagement and empowerment, digital health integration, personalized medicine and patient-centric care, market competition and innovation.
The rising prevalence of chronic respiratory diseases is anticipated to drive the demand for the spirometer market in the future. Chronic respiratory diseases are long-term conditions affecting the airways and other lung areas, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases. These conditions are linked to various factors, such as smoking, air pollution, workplace exposures, and genetic factors. Spirometers play a crucial role in managing chronic respiratory diseases by measuring lung function, enabling doctors to monitor disease progression and assess treatment effectiveness. This information is vital for adjusting medications and creating personalized care plans, ultimately improving patients' respiratory health. For instance, in July 2022, the Australian Institute of Health and Welfare, a government agency, reported that one-third (30%) of Australians indicated they had chronic respiratory conditions. Among the estimated 7.5 million Australians with these issues, 5.1 million (20% of the total population) had allergic rhinitis (hay fever), 2.7 million (11%) had asthma, and 2 million (8%) suffered from chronic sinusitis. Thus, the increasing prevalence of chronic respiratory diseases is driving demand for the spirometer market.
The expanding aging population is expected to further increase the demand for the spirometer market in the coming years. The aging population consists of individuals who are elderly or in their later life stages. This growing demographic creates a heightened need for spirometry testing, as healthcare providers focus on managing respiratory health in older adults. For example, in July 2024, the UK Parliament's House of Commons Library, a government entity, reported that in 2022, the UK had approximately 12.7 million residents aged 65 and over, accounting for 19% of the population. By 2072, this figure is projected to rise to 22.1 million, or 27% of the population. Therefore, the increasing aging population is contributing to the growing demand for the spirometer market.
Major companies in the spirometer market are concentrating on creating innovative solutions like app-based platforms to assist users in tracking lung health and sharing data with healthcare providers. These app-based platforms enable users to monitor their lung function, receive real-time feedback, and communicate with healthcare professionals for better management of respiratory conditions. For example, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing firm, introduced AsthmaGo. AsthmaGo is an advanced app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor their lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their conditions effectively and share health data with caregivers for personalized care.
Leading companies in the spirometer market are focused on developing innovative solutions such as digital platforms to enhance lung health tracking and improve communication with healthcare providers. Digital platforms encompass online systems and applications that facilitate communication, data sharing, and interaction between users and service providers, enabling features such as remote monitoring, health tracking, and virtual consultations in healthcare settings. For instance, in May 2022, NuvoAir, a US-based virtual specialty care clinic, launched a Remote Asthma Assessment Service. This service enhances asthma care by utilizing remote monitoring technologies, including the Air Next spirometer, to allow patients to track their respiratory health through the NuvoAir Home app, while healthcare providers can access detailed assessment reports to improve diagnosis and treatment, ultimately leading to better patient outcomes.
In November 2022, CAIRE Inc., a U.S.-based manufacturer of respiratory devices, acquired MGC Diagnostics Holdings, Inc. for an undisclosed sum. This acquisition allows CAIRE Inc. to expand its portfolio to include pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and related consumables. MGC Diagnostics Holdings, Inc. is known for developing non-invasive diagnostic systems aimed at detecting and managing cardiorespiratory diseases.
Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sdi Diagnostics Inc., Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.
North America was the largest region in the spirometer market share in 2024. The regions covered in the spirometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A spirometer is a device utilized to evaluate lung function by measuring the volume of air a person inhales and exhales, as well as the duration of exhalation. It serves as a diagnostic tool for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other respiratory conditions affecting breathing.
Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.
The spirometer market research report is one of a series of new reports that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The spirometer market size is expected to see strong growth in the next few years. It will grow to $1.74 billion in 2029 at a compound annual growth rate (CAGR) of 8%. The growth in the forecast period can be attributed to shift towards home healthcare, continue clinical research, medical reimbursement policies, occupational health monitoring. Major trends in the forecast period include remote monitoring and telemedicine, patient engagement and empowerment, digital health integration, personalized medicine and patient-centric care, market competition and innovation.
The rising prevalence of chronic respiratory diseases is anticipated to drive the demand for the spirometer market in the future. Chronic respiratory diseases are long-term conditions affecting the airways and other lung areas, including asthma, chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, sleep apnea, and occupational lung diseases. These conditions are linked to various factors, such as smoking, air pollution, workplace exposures, and genetic factors. Spirometers play a crucial role in managing chronic respiratory diseases by measuring lung function, enabling doctors to monitor disease progression and assess treatment effectiveness. This information is vital for adjusting medications and creating personalized care plans, ultimately improving patients' respiratory health. For instance, in July 2022, the Australian Institute of Health and Welfare, a government agency, reported that one-third (30%) of Australians indicated they had chronic respiratory conditions. Among the estimated 7.5 million Australians with these issues, 5.1 million (20% of the total population) had allergic rhinitis (hay fever), 2.7 million (11%) had asthma, and 2 million (8%) suffered from chronic sinusitis. Thus, the increasing prevalence of chronic respiratory diseases is driving demand for the spirometer market.
The expanding aging population is expected to further increase the demand for the spirometer market in the coming years. The aging population consists of individuals who are elderly or in their later life stages. This growing demographic creates a heightened need for spirometry testing, as healthcare providers focus on managing respiratory health in older adults. For example, in July 2024, the UK Parliament's House of Commons Library, a government entity, reported that in 2022, the UK had approximately 12.7 million residents aged 65 and over, accounting for 19% of the population. By 2072, this figure is projected to rise to 22.1 million, or 27% of the population. Therefore, the increasing aging population is contributing to the growing demand for the spirometer market.
Major companies in the spirometer market are concentrating on creating innovative solutions like app-based platforms to assist users in tracking lung health and sharing data with healthcare providers. These app-based platforms enable users to monitor their lung function, receive real-time feedback, and communicate with healthcare professionals for better management of respiratory conditions. For example, in May 2023, CMI Health Inc., a US-based medical equipment manufacturing firm, introduced AsthmaGo. AsthmaGo is an advanced app-based asthma management platform that integrates the SpiroLink digital spirometer, allowing users to conveniently monitor their lung performance and oxygen levels from home. This platform empowers asthma patients, including children, to manage their conditions effectively and share health data with caregivers for personalized care.
Leading companies in the spirometer market are focused on developing innovative solutions such as digital platforms to enhance lung health tracking and improve communication with healthcare providers. Digital platforms encompass online systems and applications that facilitate communication, data sharing, and interaction between users and service providers, enabling features such as remote monitoring, health tracking, and virtual consultations in healthcare settings. For instance, in May 2022, NuvoAir, a US-based virtual specialty care clinic, launched a Remote Asthma Assessment Service. This service enhances asthma care by utilizing remote monitoring technologies, including the Air Next spirometer, to allow patients to track their respiratory health through the NuvoAir Home app, while healthcare providers can access detailed assessment reports to improve diagnosis and treatment, ultimately leading to better patient outcomes.
In November 2022, CAIRE Inc., a U.S.-based manufacturer of respiratory devices, acquired MGC Diagnostics Holdings, Inc. for an undisclosed sum. This acquisition allows CAIRE Inc. to expand its portfolio to include pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and related consumables. MGC Diagnostics Holdings, Inc. is known for developing non-invasive diagnostic systems aimed at detecting and managing cardiorespiratory diseases.
Major companies operating in the spirometer market are Fukuda Sangyo Co. Ltd., Geratherm Respiratory GmbH, Jones Medical Instrument Company, Koninklijke Philips N.V., Ndd Medical Technologies Inc., nSpire Health Inc., Schiller AG, Sdi Diagnostics Inc., Sibelmed Sau, Smiths Medical Inc., Vitalograph Ltd., Vyaire Medical Inc., Welch Allyn Inc., Baxter International Inc., Benson Medical Instruments Co., Chest M.I. Inc., COSMED srl, Depisteo LLC, Henry Schein Inc., ICU Medical Inc., MGC Diagnostics Corporation, Midmark Corporation, Minato Medical Science Co Ltd., Nuvoair AB, OHD (SCHAUENBURG International, Recorders & Medicare Systems Pvt Ltd., Teleflex Incorporated, Morgan Scientific Inc., Futuremed America Inc.
North America was the largest region in the spirometer market share in 2024. The regions covered in the spirometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the spirometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A spirometer is a device utilized to evaluate lung function by measuring the volume of air a person inhales and exhales, as well as the duration of exhalation. It serves as a diagnostic tool for conditions such as asthma, chronic obstructive pulmonary disease (COPD), and various other respiratory conditions affecting breathing.
Different types of spirometers include hand-held, tabletop, and desktop variants. Hand-held spirometers are particularly employed in longitudinal epidemiological studies to measure and monitor forced expiratory volume. The hand-held segment of the spirometer market facilitates at-home lung testing without necessitating a visit to a healthcare professional. The technology within a spirometer typically involves volume measurement, flow measurement, and peak flow measurement. Spirometer products encompass the device itself, consumables, accessories, and associated software. These devices find application in conditions such as asthma, COPD, cystic fibrosis, pulmonary fibrosis, and various other respiratory conditions. They are utilized across diverse settings including hospitals, clinics, and in home healthcare scenarios.
The spirometer market research report is one of a series of new reports that provides spirometer market statistics, including spirometer industry global market size, regional shares, competitors with a spirometer market share, detailed spirometer market segments, market trends and opportunities, and any further data you may need to thrive in the spirometer industry. This spirometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The spirometer market consists of sales of whole-body plethysmographs, pneumotachometers, fully electronic spirometers, peak flow meters, incentive spirometers, and windmill-type spirometers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Spirometer Market Characteristics3. Spirometer Market Trends and Strategies4. Spirometer Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Spirometer Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Spirometer Market34. Recent Developments in the Spirometer Market
5. Global Spirometer Growth Analysis and Strategic Analysis Framework
6. Spirometer Market Segmentation
7. Spirometer Market Regional and Country Analysis
8. Asia-Pacific Spirometer Market
9. China Spirometer Market
10. India Spirometer Market
11. Japan Spirometer Market
12. Australia Spirometer Market
13. Indonesia Spirometer Market
14. South Korea Spirometer Market
15. Western Europe Spirometer Market
16. UK Spirometer Market
17. Germany Spirometer Market
18. France Spirometer Market
19. Italy Spirometer Market
20. Spain Spirometer Market
21. Eastern Europe Spirometer Market
22. Russia Spirometer Market
23. North America Spirometer Market
24. USA Spirometer Market
25. Canada Spirometer Market
26. South America Spirometer Market
27. Brazil Spirometer Market
28. Middle East Spirometer Market
29. Africa Spirometer Market
30. Spirometer Market Competitive Landscape and Company Profiles
31. Spirometer Market Other Major and Innovative Companies
35. Spirometer Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Spirometer Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on spirometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for spirometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The spirometer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- the market characteristics section of the report defines and explains the market.
- the market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- the forecasts are made after considering the major factors currently impacting the market. These include:
- the forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- the regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- the competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- the trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) by Type: Hand held, Table Top, Desktop2) by Technology: Volume Measurement, Flow Measurement, Peak Flow Measurement
3) by Product: Device, Consumables and Accessories, Software
4) by Application: Asthma, COPD, Cystic Fibrous, Pulmonary Fibrosis, Other Applications
5) by End-Use: Hospitals and Clinics, Home Healthcare
Subsegments:
1) by Hand-held: Digital Hand-held Spirometers; Mechanical Hand-held Spirometers2) by Table Top: Electronic Table Top Spirometers; Ultrasonic Table Top Spirometers
3) by Desktop: Digital Desktop Spirometers; Software-Integrated Desktop Spirometers
Key Companies Mentioned: Fukuda Sangyo Co. Ltd.; Geratherm Respiratory GmbH; Jones Medical Instrument Company; Koninklijke Philips N.V.; Ndd Medical Technologies Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Spirometer market report include:- Fukuda Sangyo Co. Ltd.
- Geratherm Respiratory GmbH
- Jones Medical Instrument Company
- Koninklijke Philips N.V.
- Ndd Medical Technologies Inc.
- nSpire Health Inc.
- Schiller AG
- Sdi Diagnostics Inc.
- Sibelmed Sau
- Smiths Medical Inc.
- Vitalograph Ltd.
- Vyaire Medical Inc.
- Welch Allyn Inc.
- Baxter International Inc.
- Benson Medical Instruments Co.
- Chest M.I. Inc.
- COSMED srl
- Depisteo LLC
- Henry Schein Inc.
- ICU Medical Inc.
- MGC Diagnostics Corporation
- Midmark Corporation
- Minato Medical Science Co Ltd.
- Nuvoair AB
- OHD (SCHAUENBURG International
- Recorders & Medicare Systems Pvt Ltd.
- Teleflex Incorporated
- Morgan Scientific Inc.
- Futuremed America Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 1.28 Billion |
| Forecasted Market Value ( USD | $ 1.74 Billion |
| Compound Annual Growth Rate | 8.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 30 |
